ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19

Huang, Yongsheng; Yu, Jing; Li, Dan; He, Kai; Liu, Wenyang; Wang, Lin; Chen, Yeshan*; Xie, Conghua*; Wu, Xiaowei*华中科技大学; 南方医科大学; 武汉大学; 中国医学科学院; 中国医学科学院北京协和医院
Scientific Reports2021-8-30DOI: 10.1038/s41598-021-96195-w
4閱讀
引用收藏
分享

摘要

Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general population, but the decline rate of the antibodies in cancer patients was unknown. In this observational study, we reported the clinical features of the 53 cancer patients infected by SARS-CoV-2 from Wuhan, China and tracked the presence of anti-SARS-CoV-2 antibodies in the patients for more than 12 months. We found the duration (days) of anti-SARS-CoV-2 IgG in the patients was significant longer in chemotherapy (mean: 175; range: 75 to 315) and radiotherapy groups (mean: 168; range: 85 to 265) than in non-chemo- or radio-therapy group (mean: 58; range: 21 to 123) after their recovery from COVID-19. We also used single-cell RNA sequencing to track the immunologic changes in a representative patient recovered from COVID-19 and found that CD8 + effective T cells, memory B cells and plasma cells were persistently activated in the patient undergoing chemotherapy. Together, our findings show that chemotherapy and radiotherapy might be beneficial to extend the duration of anti-SARS-CoV-2 IgG.

相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
Scientific Reports
發表日期
2021-08-30
卷期
第 11 卷, 第 1 期
頁碼
17381
DOI
10.1038/s41598-021-96195-w
語言
ENGLISH
期刊收錄
NSL
期刊等級
3区
成果收錄
SCIE
資助標註
Ministry of Science and Technology of the People's Republic of China [2016YFC1302203]; Natural Science Foundation of Hubei Province [2020CFB740]

作者

  • H

    Huang, Yongsheng (第一作者)

    chinese acad med sci · peking union med coll

  • Y

    Yu, Jing

    wuhan univ

查看全部 9 位作者收起作者
  • L

    Li, Dan

    chinese acad med sci · peking union med coll

  • H

    He, Kai

    southern med univ

  • L

    Liu, Wenyang

    chinese acad med sci · peking union med coll

  • W

    Wang, Lin

    chinese acad med sci · peking union med coll

  • C

    Chen, Yeshan (通訊)

    huazhong univ sci & technol

  • X

    Xie, Conghua (通訊)

    wuhan univ

  • W

    Wu, Xiaowei (通訊)

    huazhong univ sci & technol

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417